title: Restoring ovulation in beef donor cows with ovarian cysts by progesterone-releasing intravaginal silastic devices.
abstract: The objective of this study was to determine the efficacy of a progesterone-releasing intravaginal silastic device (Controlled Internal Drug Release: CIDR) for inducing ovulation in beef cows with persistent ovarian cysts. Fifteen cows with cysts and abnormal cycles for over 40 days were randomly assigned to receive either a single CIDR (CIDR group, n=9), or a CIDR containing no progesterone (blank CIDR) (BLANK group, n=6) for about 14 days. Determination of plasma progesterone levels at the beginning of CIDR treatment indicated 4 of 6 BLANK cows with non-luteinized cysts and 5 of 9 CIDR cows with non-luteinized cysts. In 5 of 6 BLANK cows, one follicular wave appeared and newly emerged dominant follicles increased in size up to 20 mm in diameter and persisted during the experiment, while one cow experienced estrus with spontaneous ovulation. In contrast, during CIDR treatment, 2 or 3 waves, in which dominant follicles were from 7 to 15 mm in diameter, appeared approximately at 7-day intervals. Within 3 days after CIDR removal, estrous behavior was detected followed by ovulation of the dominant follicle in the last wave. All CIDR cows resumed normal cyclicity with 2 follicular waves for over 2 months. Insertion of a CIDR caused a rapid increase of about 2 ng/mL in plasma progesterone. The levels were greater than 1.3 ng/mL until removal of a CIDR, then dropped under 0.3 ng/mL. Concentrations of plasma estradiol in BLANK cows increased during growth of the cystic follicles, with high levels greater than 10 pg/mL for over 10 days. In 4 of 5 cows with non-luteinized cysts, with high plasma estradiol on the day of CIDR insertion, CIDR treatment resulted in rapid decline of estradiol levels. During placement of the CIDR, estradiol levels showed no increase in the growth phase of a newly appeared dominant follicle. After CIDR removal, however, estradiol significantly increased associated with the growth of ovulatory follicles in all 9 cows. A transient increase in plasma FSH levels preceded detection of each follicular or cyst wave in both BLANK and CIDR cows. Pulse frequency and mean concentration of LH in cows with non-luteinized cysts showed values corresponding to those in normal follicular phase. However, throughout CIDR treatment, these parameters reduced to levels found in the normal luteal phase. In cows with luteinized cysts, parameters of LH secretion were as low as in the normal luteal phase before and during CIDR treatment, then increased significantly after CIDR removal. Present results indicate that treatment with CIDR proved effective in restoring ovulation and reestablishing normal cyclicity in beef donor cows with cysts persistent for a long period. The CIDR reduced and maintained LH secretion at normal luteal levels, thereby, inducing atresia of estrogen-active cysts and preventing formation of cysts from the newly emerged follicles.
authors: Cattle Breeding Development Institute, Kagoshima Prefecture, Japan.
authors: J
authors: J
authors: Todoroki
authors: H
authors: H
authors: Yamakuchi
authors: K
authors: K
authors: Mizoshita
authors: N
authors: N
authors: Kubota
authors: N
authors: N
authors: Tabara
authors: J
authors: J
authors: Noguchi
authors: K
authors: K
authors: Kikuchi
authors: G
authors: G
authors: Watanabe
authors: K
authors: K
authors: Taya
authors: H
authors: H
authors: Kaneko
mesh_terms: D000282:Administration, Intravaginal; D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy / Q000503:physiopathology*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004129:Dimethylpolysiloxanes; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D010048:Ovarian Cysts / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D006080:Ovarian Follicle / Q000378:metabolism; D010060:Ovulation; D011374:Progesterone / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D011673:Pulsatile Flow; D011863:Radioimmunoassay / Q000662:veterinary; D012828:Silicones
chemical_list: D003692:Delayed-Action Preparations; D004129:Dimethylpolysiloxanes; D012828:Silicones; D011374:Progesterone; D004958:Estradiol; C013830:baysilon; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone